期刊文献+

同期放化疗治疗Ⅲ~Ⅳa期鼻咽癌的前瞻性研究 被引量:1

Prospective Study of Concurrent Chemotherapy and Radiotherapy for Ⅲ-Ⅳa Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的探讨同期放化疗能否提高Ⅲ-Ⅳa期鼻咽癌的疗效。方法92例Ⅲ-Ⅳa期鼻咽癌患者随机分为两组。A组,单纯常规放疗组46例。B组,常规放疗+同期化疗46例。两组放疗方案相同均选用6MVX线外照射或6-12MeV电子线(用于颈部淋巴结转移灶的剂量补充照射)放射技术为面颈联合野DT38Gy后,改耳前野避开脊髓加量及颈部切线野、上颈电子线外照射。原发灶和阳性淋巴结区DT70-76Gy/35-38次,7-8周,预防区DT50-60Gy/25-30次,5-6周。化疗方案为DDP40mg静脉滴注,d1-3,平阳霉素16mg静脉滴注,d1-3,每4周为1个疗程,共2个疗程,放射治疗开始于化疗结束后第2天进行。结果3年无瘤生存率(DFS)A组47.8%(22/46)、B组71.7%(33/46),两者差异有统计学意义(χ^2=5.47,P〈0.05)。3年总生存率(OS)A组58.7%(27/46),B组73.9%(34/46),两者差异无统计学意义(χ^2=2.38,P〉0.05)。结论同期放化疗能提高中晚期鼻咽癌的无瘤生存率,对总生存率的提高也有一定的帮助。毒副反应虽有增加,但患者均能耐受。 Objective To evaluate the efficacy of concurrent chemotherapy and radiotherapy for Ⅲ-Ⅳa nasopharyngeal carcinoma. Methods From Oct. 200i to Oct. 2002, 92 patients of stage Ⅲ-Ⅳa nasopharyngeal carcinoma were randomized into radiotherapy alone group (A group, 46 patients) or concurrent chemotherapy group ( B group, 46 patients). All patients of A and B groups received radiotherapy by 6 MV X-ray or 6-12 MeV 13-ray. Radiotherapy was delivered by 6 MV X-ray facial-cervical part was first used to give DT 38 Gy followed by pro-auricular fields or neck fields. The dose at the primary lesion and metastastic lymph node were usually DT 70-76 Gy/35-38 fractionation in 7-8 weeks. DT 50-60 Gy was used prophylactically for the neck region which had been from metastasis. Before radical radiotherapy patients of B group received cisplatin(DDP) 40 mg on days 1-3 and bleomycin A5 16 mg on days 1-3 every four weeks as one cycle to totally 2 cycles. Radiotherapy was used after second day of completed chemotherapy. Results The 3-year disease-free survival rates (DFS) were 47.8% (22/46) in A group, 71.7% (33/46) in B group respectively. Two groups had difference (P 〈 0.05 ). The 3-year overall survival rate (OS) were 58.7% (27/46) in A group, 73.9% (34/46) in B group. Two groups had no difference (P〉0.05). Conclusions Concurrent chemotherapy and radiotherapy for Ⅲ-Ⅳa nasopharyngeal carcinoma can improve disease-free survival rates(DFS) and help to improve overall survival rate (OS). Although the toxicities had increase, the patients can he tolerated.
出处 《肿瘤基础与临床》 2008年第1期55-56,共2页 journal of basic and clinical oncology
关键词 鼻咽癌 放射治疗 化学治疗 nasopharyngeal carcinoma radiotherapy chemotherapy
  • 相关文献

参考文献5

  • 1周际昌.抗肿瘤药的不良反应及处理[A]..实用肿瘤内科学[C].北京:人民卫生出版社,1998.24~32. 被引量:13
  • 2崔念基,卢泰祥,邓小武主编..实用临床放射肿瘤学[M].广州:中山大学出版社,2005:767.
  • 3Farias TP, Dias FL, Lima RA, et al. Prognostic factors and outcome for nasopharyngeal carcinoma[ J]. Arch Otolaryngol Head Neck Surg, 2003, 129(7) : 794 -799. 被引量:1
  • 4Lin JC, Jan JS, Hsu CY, et al. Phase Ⅲ study of concurrent chemoradiotherapy versus radiotherapy alone for advanced nasopharyngeal carcinoma: positive effect on overall and progression-free survival[ J ]. J Clin Oneo1,2003,21 (4) :631 - 637. 被引量:1
  • 5Lee AW, Lau WH, Tung SY, et al. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma:NPC-9901 trial by the Hong Kong Nasopharyngeal Cancer Study Group[ J]. J Clin Onco1,2005,23 (28) :6966 -6975. 被引量:1

共引文献12

同被引文献63

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部